Inward Investment
Sagent Pharmaceuticals to acquire remaining stake in KSPC JV
By
Sagent Pharmaceuticals has signed an agreement to acquire 50% interest of its joint venture (JV) partner, Chengdu Kanghong Pharmaceuticals, in the Kanghong Sagent Pharmaceutical (KSPC) JV, for $25m.
Inward Investment > News
Sagent Pharmaceuticals has signed an agreement to acquire 50% interest of its joint venture (JV) partner, Chengdu Kanghong Pharmaceuticals, in the Kanghong Sagent Pharmaceutical (KSPC) JV, for $25m.
Inward Investment > News
ChemRar signs scouting pharma partnering agreement with Sanofi
By
ChemRar Ventures has entered into scouting agreement with Sanofi for a venture investment in Russia and Asia.
Inward Investment > News Parexel acquires Heron Group By
Parexel, a US-based clinical research organization, has acquired the equity securities of the Heron Group, a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products.
Inward Investment > News
ChemRar Ventures has entered into scouting agreement with Sanofi for a venture investment in Russia and Asia.
Inward Investment > News Parexel acquires Heron Group By
Parexel, a US-based clinical research organization, has acquired the equity securities of the Heron Group, a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products.
Inward Investment > News
Latest Inward Investment News and Insight
View all Inward Investment news or find news targeted to your interests
Merck funds Canadian life sciences research
Merck Canada will provide $4m to the Institute for Research in Immunology and Cancer - Commercialization of Research (IRICoR) for future corridor projects, which are developed in association with two other Canadian Centres of Excellence for Commercialization and Research (CECRs) in Ontario and in British Columbia.
Inward Investment > News
Inward Investment > News
Eli Lilly acquires Siemens investigational PET tracers for Alzheimer's research
Eli Lilly and Company has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA.
Inward Investment > News
Inward Investment > News
Ares Life Sciences to acquire US firm Antigen Laboratories
Ares Life Sciences, a Switzerland-based healthcare-focused investment group, has signed a definitive agreement to acquire the complete share capital of Planet Biopharmaceuticals.
Inward Investment > News
Inward Investment > News
Water Street invests in pharmaceutical services company
Private equity firm Water Street Healthcare Partners has invested in CCBR-SYNARC, to expand its global presence in the pharmaceutical services sector.
Inward Investment > News
Inward Investment > News
Mobidiag, Genewave, Amplidiag merge to develop new diagnostic tests for infectious diseases
Mobidiag, Genewave and Amplidiag have signed a definitive agreement to combine the three companies to set up a new company, which will offer integrated, high-multiplex diagnostic tests for infectious diseases.
Inward Investment > News
Inward Investment > News
AmerisourceBergen to sell Canadian pharmaceutical distribution business
AmerisourceBergen has signed a definitive agreement to sell its Canadian pharmaceutical distribution business, AmerisourceBergen Canada (ABCC), to Canadian-owned national full-line distributor Kohl & Frisch.
Inward Investment > News
Inward Investment > News
Clinigen acquires Cardioxane from Novartis
Clinigen has acquired Cardioxane (dexrazoxane) from Novartis for $33m, which is payable in two tranches.
Inward Investment > News
Inward Investment > News
Sanofi to expand manufacturing operations in Vietnam
Sanofi is investing $75m in a new manufacturing facility in the Saigon High Tech Park - Ho Chi Minh City, Vietnam.
Inward Investment > News
Inward Investment > News
BioPharm Product and Services
Infinata supports a wide range of needs of the industry and related products and services through our comprehensive BioPharm Solutions Suite. Learn more about how we can help you:
Inward Investment > Products
Inward Investment > Products
The Emergence of Real-Time Intelligence to Overcome Limits of Traditional Biopharma Market Research
With heightened competition throughout the global biopharma landscape, the demand for business intelligence (BI) has intensified – as has the need for new tools and information to provide BI departments with an actionable edge. This white paper outlines innovative new methods being used by BI thought leaders to achieve that elusive edge.
Inward Investment > White Papers
View all Inward Investment news or find news targeted to your interests
Inward Investment > White Papers
Buy the latest industry research online today!
UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" is a crucial resource for industry executives and anyone looking to access key information about "UnitedHealth Group Incorporated"
ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Buy online from $125
